Clinical Research Directory

Inclusion Criteria: * HIV-1 infected men or women * Aged 18-65 * Stable insurance plan * Documented plasma HIV-1 RNA \< 50 c/mL x 2 within the last year prior to screening * Must be on a stable ARV regimen for ≥6 months prior to screening * CD4+T-cell count\<350 cells/mm3 while on ARVs for at least 2 years * Must be willing to add FTR 600 mg twice daily to their current antiretroviral regimen * Must have attended ≥ 2 clinic visits in the 12 months prior to screening Exclusion Criteria: * Newly or recently diagnosed HIV-1 infection defined as HIV-1 infection diagnosed in the prior 6 months * Active HBV or HCV co-infection * Unstable liver disease or Child-Pugh C liver disease * History of autoimmune disease * History of any malignancy ≤5 years * History of radiation or cytotoxic chemotherapy * Use of systemic corticosteroids or other immunomodulatory agents in the last 14 days prior to study entry * Confirmed QT value \> 500 msec at Screening or Day 1 or confirmed QTcF value \> 470 msec for women and \> 450 msec for men at Screening or Day 1